Abstract |
A dose- and vehicle-controlled study on the pretreatment and posttreatment effect of 0.1% tacrolimus ointment on erythema induced by solar-simulated ultraviolet (UV) radiation was performed. Surprisingly, comparisons of clinical erythema scores and colorimetric data obtained 24 and 72 hours after UV exposure did not reveal significant differences between the control, tacrolimus, and vehicle preirradiation and postirradiation treated sites (P > .05). Our data strongly indicate that topical tacrolimus neither prevents nor abolishes UV-induced erythema in a clinical meaningful degree.
|
Authors | Thilo Gambichler, Nordwig S Tomi, Georg Moussa, Julia Huyn, Heinrich Dickel, Peter Altmeyer, Alexander Kreuter |
Journal | Journal of the American Academy of Dermatology
(J Am Acad Dermatol)
Vol. 55
Issue 5
Pg. 882-5
(Nov 2006)
ISSN: 1097-6787 [Electronic] United States |
PMID | 17052498
(Publication Type: Controlled Clinical Trial, Journal Article)
|
Chemical References |
- Anti-Inflammatory Agents
- Tacrolimus
|
Topics |
- Administration, Topical
- Adult
- Anti-Inflammatory Agents
(administration & dosage, therapeutic use)
- Dose-Response Relationship, Drug
- Erythema
(drug therapy, etiology, prevention & control)
- Female
- Humans
- Male
- Middle Aged
- Tacrolimus
(administration & dosage, therapeutic use)
- Treatment Failure
- Ultraviolet Rays
|